Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients
- 20 June 2013
- journal article
- clinical trial
- Published by Wiley in American Journal of Hematology
- Vol. 88 (8) , 647-651
Abstract
Most previous studies on telomere length (TL) in chronic lymphocytic leukemia (CLL) are based on referral cohorts including a high proportion of aggressive cases. Here, the impact of TL was analyzed in a population‐based cohort of newly diagnosed CLL (n = 265) and in relation to other prognostic markers. Short telomeres were particularly associated with high‐risk genetic markers, such as NOTCH1, SF3B1, or TP53 aberrations, and predicted a short time to treatment (TTT) and overall survival (OS) (both P < 0.0001). TL was an independent prognostic factor and subdivided patients with otherwise good‐prognostic features (e.g., mutated IGHV genes, favorable cytogenetics) into subgroups with different outcome. Furthermore, in follow‐up samples (n = 119) taken 5–8 years after diagnosis, TL correlated well with TL at diagnosis and remained unaffected by treatment. Altogether, these novel data indicate that short TL already at diagnosis is associated with poor outcome in CLL and that TL can be measured at later stages of the disease. Am. J. Hematol. 88:647–651, 2013.Keywords
This publication has 27 references indexed in Scilit:
- Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Leukemia & Lymphoma, 2013
- Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologiesLeukemia & Lymphoma, 2013
- RNA-based markers as prognostic factors in chronic lymphocytic leukemiaExpert Review of Hematology, 2012
- Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulationBlood, 2011
- Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisisBlood, 2010
- Prognostic markers in chronic lymphocytic leukemia: A comprehensive reviewBlood Reviews, 2009
- Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation statusBlood, 2005
- Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutationsBlood, 2004
- Association between telomere length and VH gene mutation status in chronic lymphocytic leukaemia: clinical and biological implicationsBritish Journal of Cancer, 2003
- Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesisOncogene, 2002